Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 4
1986 6
1987 3
1988 2
1989 1
1990 3
1991 1
1992 2
1993 3
1994 4
1995 5
1996 8
1997 5
1998 11
1999 9
2000 4
2001 8
2002 8
2003 8
2004 7
2005 12
2006 13
2007 18
2008 32
2009 36
2010 48
2011 45
2012 81
2013 66
2014 85
2015 96
2016 69
2017 46
2018 74
2019 93
2020 114
2021 121
2022 111
2023 104
2024 73
2025 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,279 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean t shafiei (341 results)?
Hormonal Therapy for Prostate Cancer.
Desai K, McManus JM, Sharifi N. Desai K, et al. Endocr Rev. 2021 May 25;42(3):354-373. doi: 10.1210/endrev/bnab002. Endocr Rev. 2021. PMID: 33480983 Free PMC article. Review.
Kefir: a powerful probiotics with anticancer properties.
Sharifi M, Moridnia A, Mortazavi D, Salehi M, Bagheri M, Sheikhi A. Sharifi M, et al. Med Oncol. 2017 Sep 27;34(11):183. doi: 10.1007/s12032-017-1044-9. Med Oncol. 2017. PMID: 28956261 Review.
Many studies revealed that kefir acts on different cancers such as colorectal cancer, malignant T lymphocytes, breast cancer and lung carcinoma. In this review, we have focused on anticancer properties of kefir....
Many studies revealed that kefir acts on different cancers such as colorectal cancer, malignant T lymphocytes, breast cancer and lung …
CD8+ T Cells Play a Bystander Role in Mice Latently Infected with Herpes Simplex Virus 1.
Mott KR, Gate D, Matundan HH, Ghiasi YN, Town T, Ghiasi H. Mott KR, et al. J Virol. 2016 Apr 29;90(10):5059-5067. doi: 10.1128/JVI.00255-16. Print 2016 May 15. J Virol. 2016. PMID: 26962220 Free PMC article.
Based on an explant reactivation model, it has been proposed that CD8(+) T cells maintain latency in trigeminal ganglia (TG) of mice latently infected with herpes simplex virus 1 (HSV-1) [T. ...Mott, S. J. Allen, M. Zandian, B. Konda, B. G. Sharifi, C. Jones, …
Based on an explant reactivation model, it has been proposed that CD8(+) T cells maintain latency in trigeminal ganglia (TG) of mice …
The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy.
Hajibabaie F, Abedpoor N, Haghjooy Javanmard S, Hasan A, Sharifi M, Rahimmanesh I, Shariati L, Makvandi P. Hajibabaie F, et al. Environ Res. 2023 Nov 15;237(Pt 2):116980. doi: 10.1016/j.envres.2023.116980. Epub 2023 Aug 28. Environ Res. 2023. PMID: 37648188 Free article. Review.
Combination therapy targeting multiple pathways simultaneously has been shown to be promising in treating melanoma, eliciting favorable responses in most melanoma patients. CAR T-cells, engineered to overcome the limitations of human leukocyte antigen (HLA)-dependent tumor …
Combination therapy targeting multiple pathways simultaneously has been shown to be promising in treating melanoma, eliciting favorable resp …
1,279 results